DOCSLIB.ORG

Crimean-Congo Hemorrhagic Fever in Afghanistan

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Crimean-Congo Hemorrhagic Fever in Afghanistan Weekly Epidemiological Monitor ISSN 2224-4220 Volume 10; Issue no 51; 17 December 2017 Current major event Crimean-Congo Hemorrhagic Fever reported in Afghanistan, 2017 Crimean-Congo hemorrhagic Cases Deaths CFR (%) fever in Afghanistan 50 60 The Ministry of Public Health in Afghan- 50 istan recently reported an increase in the 40 40 number of Crimean-Congo haemorrhagic 30 fever (CCHF) cases in the country. In 30 20 2017, a total of 237 cases of CCHF in- 20 cluding 41 deaths (CFR: 17.2%) have 10 10 been reported throughout 27 provinces. 0 0 Majority of these cases-71 cases including Case Fatality Rate (% ) 13 associated deaths (CFR: 18.3%), were Jan Feb Mar Apr May Jun Jul Aug Sept Oct Nov Dec Month reported from the capital city, Kabul. Num bandCases Deaths erof Editorial note Geographical distribution of CCHF cases and deaths in Afghanistan, 2017 Update on outbreaks Crimean-Congo haemorrhagic fever is a in the Eastern Mediterranean Region widespread tick-borne viral disease that results in severe viral haemorrhagic fever MERS in Saudi Arabia; cholera in Soma- outbreaks, with a high CFR of 10–40%. lia; cholera in Yemen; dengue in Hosts of CCHF virus include a wide Pakistan. range of wild and domestic animals such as cattle, sheep and goats. The CCHF Current public health events of virus is transmitted to people either by international concern tick bites or through contact with infected [cumulative No of cases (deaths), CFR %] animal blood or tissues during and imme- diately after slaughter. Human-to-human Avian influenza: 2006-2017 transmission can occur resulting from Egypt (A/H5N1) [359 (122), 34%] close contact with the blood, secretions, Egypt (A/H9N2) [4 (0)] organs or other bodily fluids of infected The increase in the slaughtering of ani- persons. mals during this time period might have Avian influenza A (H7N9): 2013-2017 CCHF is endemic in some countries of significantly increased the risk of CCHF the Eastern Mediterranean Region of virus transmission. This trend is con- China [1,564 (612), 39.1%] WHO and particularly in Afghanistan. sistent with the last outbreaks in the Chikungunya: 2016-2017 An average of 5 to 50 human cases are country. reported every year in the country. The The high risk groups for contracting Pakistan [8,363 (0)] last most severe outbreak of the disease CCHF include animal herders, livestock Cholera: 2016-2017 occurred in 2016, when 156 cases includ- workers, butchers, slaughterhouse work- ing 18 deaths (CFR: 11.5%) were report- ers and veterinarians. Health care work- Somalia [78,784 (1,159), 1.5%] ed. ers are also at risk of infection through Yemen [983,484 (2,225), 0.23%] In 2017, the total number of cases report- unprotected contact with infectious ed is 237 including 41 deaths (CFR: blood and body fluids while caring for Plague: 2017 17.2%). The male to female ratio of cases patients. Madagascar [2,417 (209), 9%] in 27 out of 34 provinces is 2:1. Out of Prevention and control interventions for the total reported cases, 26 were labora- CCHF need to be strengthened. This Dengue fever: 2017 tory confirmed. The highest number of should include effective coordination Pakistan [125,316 (69), 0.1%] cases was reported in Kabul and Herat between human and animal health sec- provinces. Herat province has an endem- tors and other relevant stakeholders. As MERS: 2012-2017 ic foci for CCHF. A total of 67 cases in- there is no vaccine available either for cluding 10 deaths (CFR: 14.9%) were humans or animals, prevention measures Saudi Arabia [1,751 (682), 38.9%] reported from this province. These two are crucial. Protective gear should be Wild poliovirus: 2014-2017 provinces border Pakistan and Iran (see utilised by animal handlers while dealing figure) where livestock transboundary with infected animals and healthcare Pakistan [7 (0)] movement is not controlled. workers while dealing with suspected Afghanistan [12 (0)] Majority of CCHF cases and deaths in cases. Community awareness and risk Afghanistan were recorded from June to communication through sessions, elec- Zika virus infection: 2015-2017 September (see graph) around the time of tronic and print media, is the key to pre- vent the virus/infection spread. 84 countries and territories have reported Eid Al-Adha (sacrifice feast in Islam). transmission so far. Published by World Health Organization, Regional Office for Eastern Mediterranean, Cairo, Egypt Tel: +20 2 22765273 Fax: +20 2 2765456 Email: [email protected] Previous issues are available at http://www.emro.who.int/surveillance-forecasting-response/weekly-epidemiological-monitor/ 51 .
Load more

Recommended publications
  • Arizona Arboviral Handbook for Chikungunya, Dengue, and Zika Viruses
    ARIZONA ARBOVIRAL HANDBOOK FOR CHIKUNGUNYA, DENGUE, AND ZIKA VIRUSES 7/31/2017 Arizona Department of Health Services | P a g e 1 Arizona Arboviral Handbook for Chikungunya, Dengue, and Zika Viruses Arizona Arboviral Handbook for Chikungunya, Dengue, and Zika Viruses OBJECTIVES .............................................................................................................. 4 I: CHIKUNGUNYA ..................................................................................................... 5 Chikungunya Ecology and Transmission ....................................... 6 Chikungunya Clinical Disease and Case Management ............... 7 Chikungunya Laboratory Testing .................................................. 8 Chikungunya Case Definitions ...................................................... 9 Chikungunya Case Classification Algorithm ............................... 11 II: DENGUE .............................................................................................................. 12 Dengue Ecology and Transmission .............................................. 14 Dengue Clinical Disease and Case Management ...................... 14 Dengue Laboratory Testing ......................................................... 17 Dengue Case Definitions ............................................................ 19 Dengue Case Classification Algorithm ....................................... 23 III: ZIKA ..................................................................................................................
    [Show full text]
  • Dengue Fever and Dengue Hemorrhagic Fever (Dhf)
    DENGUE FEVER AND DENGUE HEMORRHAGIC FEVER (DHF) What are DENGUE and DHF? Dengue and DHF are viral diseases transmitted by mosquitoes in tropical and subtropical regions of the world. Cases of dengue and DHF are confirmed every year in travelers returning to the United States after visits to regions such as the South Pacific, Asia, the Caribbean, the Americas and Africa. How is dengue fever spread? Dengue virus is transmitted to people by the bite of an infected mosquito. Dengue cannot be spread directly from person to person. What are the symptoms of dengue fever? The most common symptoms of dengue are high fever for 2–7 days, severe headache, backache, joint pains, nausea and vomiting, eye pain and rash. The rash is frequently not visible in dark-skinned people. Young children typically have a milder illness than older children and adults. Most patients report a non-specific flu-like illness. Many patients infected with dengue will not show any symptoms. DHF is a more severe form of dengue. Initial symptoms are the same as dengue but are followed by bleeding problems such as easy bruising, skin hemorrhages, bleeding from the nose or gums, and possible bleeding of the internal organs. DHF is very rare. How soon after exposure do symptoms appear? Symptoms of dengue can occur from 3-14 days, commonly 4-7 days, after the bite of an infected mosquito. What is the treatment for dengue fever? There is no specific treatment for dengue. Treatment usually involves treating symptoms such as managing fever, general aches and pains. Persons who have traveled to a tropical or sub-tropical region should consult their physician if they develop symptoms.
    [Show full text]
  • Your Child Or Family Member May Have Dengue Fever According to Their Clinical History and Physical Examination
    Your child or family member may have dengue fever according to their clinical history and physical examination. If it is dengue, serious complications of the disease can develop. If the complications are recognized early, and a doctor is consulted, it may save the patient’s life. Your doctor can order more tests to see if the patient needs to be hospitalized. The doctor can also order specific tests for dengue, but those tests will take longer than a week for the results to come back. How to Care for the Patient While They Have a Fever: Bed rest. Let patient rest as much as possible. Control the fever. Give acetaminophen or paracetamol (Tylenol) every 6 hours (maximum 4 doses per day). Do not give ibuprofen (Motrin, Advil) aspirin, or aspirin containing drugs. Sponge patient’s skin with cool water if fever stays high. Prevent dehydration which occurs when a person loses too much fluid (from high fevers, vomiting, or poor oral intake). Give plenty of fluids and watch for signs of dehydration. Bring patient to clinic or emergency room if any of the following signs develop: Decrease in urination (check number of wet diapers or trips to the bathroom) Few or no tears when child cries Dry mouth, tongue or lips Sunken eyes Listlessness or overly agitated or confused Fast heart beat (more than 100/min) Cold or clammy fingers and toes Sunken fontanel in infant DO WHILE THE PATIENT HAS FEVER DO WHILE THE PATIENT Prevent spread of dengue within your house. Place patient under bed net or use insect repellent on the patient while they have a fever.
    [Show full text]
  • Dengue and Yellow Fever
    GBL42 11/27/03 4:02 PM Page 262 CHAPTER 42 Dengue and Yellow Fever Dengue, 262 Yellow fever, 265 Further reading, 266 While the most important viral haemorrhagic tor (Aedes aegypti) as well as reinfestation of this fevers numerically (dengue and yellow fever) are insect into Central and South America (it was transmitted exclusively by arthropods, other largely eradicated in the 1960s). Other factors arboviral haemorrhagic fevers (Crimean– include intercontinental transport of car tyres Congo and Rift Valley fevers) can also be trans- containing Aedes albopictus eggs, overcrowding mitted directly by body fluids. A third group of of refugee and urban populations and increasing haemorrhagic fever viruses (Lassa, Ebola, Mar- human travel. In hyperendemic areas of Asia, burg) are only transmitted directly, and are not disease is seen mainly in children. transmitted by arthropods at all. The directly Aedes mosquitoes are ‘peri-domestic’: they transmissible viral haemorrhagic fevers are dis- breed in collections of fresh water around the cussed in Chapter 41. house (e.g. water storage jars).They feed on hu- mans (anthrophilic), mainly by day, and feed re- peatedly on different hosts (enhancing their role Dengue as vectors). Dengue virus is numerically the most important Clinical features arbovirus infecting humans, with an estimated Dengue virus may cause a non-specific febrile 100 million cases per year and 2.5 billion people illness or asymptomatic infection, especially in at risk.There are four serotypes of dengue virus, young children. However, there are two main transmitted by Aedes mosquitoes, and it is un- clinical dengue syndromes: dengue fever (DF) usual among arboviruses in that humans are the and dengue haemorrhagic fever (DHF).
    [Show full text]
  • Florida Arbovirus Surveillance Week 13: March 28-April 3, 2021
    Florida Arbovirus Surveillance Week 13: March 28-April 3, 2021 Arbovirus surveillance in Florida includes endemic mosquito-borne viruses such as West Nile virus (WNV), Eastern equine encephalitis virus (EEEV), and St. Louis encephalitis virus (SLEV), as well as exotic viruses such as dengue virus (DENV), chikungunya virus (CHIKV), Zika virus (ZIKV), and California encephalitis group viruses (CEV). Malaria, a parasitic mosquito-borne disease is also included. During the period of March 28- April 3, 2021, the following arboviral activity was recorded in Florida. WNV activity: No human cases of WNV infection were reported this week. No horses with WNV infection were reported this week. No sentinel chickens tested positive for antibodies to WNV this week. In 2021, positive samples from two sentinel chickens has been reported from two counties. SLEV activity: No human cases of SLEV infection were reported this week. No sentinel chickens tested positive for antibodies to SLEV this week. In 2021, no positive samples have been reported. EEEV activity: No human cases of EEEV infection were reported this week. No horses with EEEV infection were reported this week. No sentinel chickens tested positive for antibodies to EEEV this week. In 2021, positive samples from one horse and 14 sentinel chickens have been reported from four counties. International Travel-Associated Dengue Fever Cases: No cases of dengue fever were reported this week in persons that had international travel. In 2021, one travel-associated dengue fever case has been reported. Dengue Fever Cases Acquired in Florida: No cases of locally acquired dengue fever were reported this week. In 2021, no cases of locally acquired dengue fever have been reported.
    [Show full text]
  • Mosquito-Born Dengue Fever Threat Spreading in the Americas
    NRDC Issue Paper July 2009 Fever Pitch Mosquito-Borne Dengue Fever Threat Spreading in the Americas Authors Kim Knowlton, Dr.P.H. Gina Solomon, M.D., M.P.H. Miriam Rotkin-Ellman, M.P.H. Natural Resources Defense Council About NRDC The Natural Resources Defense Council (NRDC) is an international nonprofit environmental organization with more than 1.2 million members and online activists. Since 1970, our lawyers, scientists, and other environmental specialists have worked to protect the world’s natural resources, public health, and the environment. NRDC has offices in New York City, Washington, D.C., Los Angeles, San Francisco, Chicago, Montana, and Beijing. Visit us at www.nrdc.org. Acknowledgments The authors would like to thank Zev Ross and Hollie Kitson of ZevRoss Spatial Analysis, Ithaca, New York, for conducting the mapping, and to Sashti Balasundaram for dengue case data research. Dr. Chester G. Moore of Colorado State University generously provided access to mosquito occurrence data. We would also like to thank Cindy and Alan Horn for their support of NRDC’s Global Warming and Health Project. We are grateful to the following peer reviewers who provided invaluable comments on this report: Chester Moore, Colorado State University; Kristie L. Ebi, ESS, LLC; Joan Brunkard, U.S. Centers for Disease Control and Prevention; Mary Hayden, National Center for Atmospheric Research Institute for the Study of Society and Environment. NRDC Director of Communications: Phil Gutis NRDC Marketing and Operations Director: Alexandra Kennaugh NRDC Publications Director: Lisa Goffredi NRDC Publications Editor: Anthony Clark Production: Jon Prinsky Copyright 2009 by the Natural Resources Defense Council.
    [Show full text]
  • Viral Hemorrhagic Fevers and Bioterrorism
    What you need to know about . Viral Hemorrhagic Fevers and Bioterrorism What are viral hemorrhagic fevers? How are viral hemorrhagic fevers Viral hemorrhagic fevers (VHFs) are a spread? group of illnesses caused by several distinct In nature, viruses causing hemorrhagic fever families of viruses. In general the term typically are passed from mice, rats, fleas “viral hemorrhagic fever” describes severe and ticks to humans. People can be infected problems affecting several organ systems when they come in contact with urine, fecal in the body. Typically, the entire system of ma�er, saliva or other body fluids from blood vessels is damaged, and the body has infected rodents. Fleas and ticks transmit the problems regulating itself. Symptoms o�en viruses when they bite a person or when a include bleeding, but the bleeding itself is person crushes a tick. Hosts for some viruses rarely life-threatening. VHFs are caused by such as Ebola and Marburg are not known. viruses of four families: Some viruses such as Ebola, Marburg and Lassa can be spread from person to person • Arenavirus including Lassa fever and by direct contact with infected blood or Argentine, Bolivian, Brazilian and organs or indirectly through contact with Venezuelan hemorrhagic fevers; objects such as syringes or needles that are • Filovirus including Ebola and Marburg; contaminated with infected body fluids. • Bunyavirus including Hantavirus and Ri� Valley Fever; What are the symptoms? • Flavivirus including yellow fever and Symptoms vary with the different virus dengue fever. families, but first signs o�en include sudden fever, weakness, muscle pain, tiredness, Can viral hemorrhagic fevers be used headache and sore throat.
    [Show full text]
  • Dengue Fever/Severe Dengue Fever/Chikungunya Fever! Report on Suspicion of Infection During Business Hours
    Dengue Fever/Severe Dengue Fever/Chikungunya Fever! Report on suspicion of infection during business hours PROTOCOL CHECKLIST Enter available information into Merlin upon receipt of initial report Review background information on the disease (see Section 2), case definitions (see Section 3 for dengue and for chikungunya), and laboratory testing (see Section 4) Forward specimens to the Florida Department of Health (DOH) Bureau of Public Health Laboratories (BPHL) for confirmatory laboratory testing (as needed) Inform local mosquito control personnel of suspected chikungunya or dengue case as soon as possible (if applicable) Inform state Arbovirus Surveillance Coordinator on suspicion of locally acquired arbovirus infection Contact provider (see Section 5A) Interview case-patient Review disease facts (see Section 2) Mode of transmission Ask about exposure to relevant risk factors (see Section 5. Case Investigation) History of travel, outdoor activities, and mosquito bites two weeks prior to onset History of febrile illness or travel for household members or other close contacts in the month prior to onset History of previous arbovirus infection or vaccination (yellow fever, Japanese encephalitis) Provide education on transmission and prevention (see Section 6) Awareness of mosquito-borne diseases Drain standing water at least weekly to stop mosquitoes from multiplying Discard items that collect water and are not being used Cover skin with clothing or Environmental Protection Agency (EPA)-registered repellent such as DEET (N,N-diethyl-meta-toluamide) Use permethrin on clothing (not skin) according to manufacturer’s directions Cover doors and windows with intact screens to keep mosquitoes out of the house Enter additional data obtained from interview into Merlin (see Section 5D) Arrange for a convalescent specimen to be taken (if necessary) Dengue/Chikungunya Guide to Surveillance and Investigation Dengue Fever/Severe Dengue/Chikungunya 1.
    [Show full text]
  • Case Report Crimean-Congo Hemorrhagic Fever in a Dengue
    Case Report Crimean-Congo hemorrhagic fever in a dengue-endemic region: lessons for the future Farheen Ali1, Taimur Saleem2, Umair Khalid2, Syed Faisal Mehmood1, Bushra Jamil3 1Department of Medicine, Aga Khan University, Stadium Road, Karachi 74800, Pakistan 2Medical College, Aga Khan University, Stadium Road, Karachi 74800, Pakistan 3Departments of Medicine and Pathology and Microbiology, Aga Khan University, Stadium Road, Karachi 74800, Pakistan Abstract Crimean-Congo hemorrhagic fever and dengue hemorrhagic fever are endemic in Pakistan. However, the overlap of geographic distribution and early clinical features between the two conditions make a reliable diagnosis difficult in the initial stage of illness. A 16-year-old boy presented with a history of hematemesis and high-grade fever. A preliminary diagnosis of dengue hemorrhagic fever was made and supportive treatment was instituted; however, the patient continued to deteriorate clinically. Dengue IgM antibody testing was negative on the third day of admission. Qualitative polymerase chain reaction test for Crimean-Congo hemorrhagic fever viral RNA was sent but the patient expired shortly after the results became available on the sixth day of admission. Considerable resources had to be expended on contact tracing and administration of ribavirin prophylaxis to all the health-care workers who had come in contact with the patient. It is crucial that Crimean-Congo hemorrhagic fever be recognized and treated at an early stage because of longer term financial and health implications for contacts such as health-care workers in the setting of a developing country. Increased surveillance of dengue and Crimean-Congo hemorrhagic fever cases is warranted for the derivation of reasonably reliable, cost-effective and prompt predictors of disease diagnosis.
    [Show full text]
  • Dengue Fever (Breakbone Fever, Dengue Hemorrhagic Fever)
    Division of Disease Control What Do I Need to Know? Dengue Fever (breakbone fever, dengue hemorrhagic fever) What is Dengue Fever? Dengue fever is a serious form of mosquito-borne disease caused one of four closely related viruses called Flaviviruses. They are named DENV 1, DENV 2, DENV 3, or DENV 4. The disease is found in most tropical and subtropical areas (including some islands in the Caribbean, Mexico, most countries of South and Central America, the Pacific, Asia, parts of tropical Africa and Australia). Almost all cases reported in the continental United States are in travelers who have recently returned from countries where the disease circulates. Dengue is endemic to the U.S. territories of Puerto Rico, the Virgin Islands, and Guam and in recent years non-travel related cases have been found in Texas, Florida, and Hawaii. Who is at risk for Dengue Fever? Dengue fever may occur in people of all ages who are exposed to infected mosquitoes. The disease occurs in areas where the mosquitos that carry dengue circulate, usually during the rainy seasons when mosquito populations are at high numbers. What are the symptoms of Dengue Fever? Dengue fever is characterized by the rapid development of fever that may last from two to seven days, intense headache, joint and muscle pain and a rash. The rash develops on the feet or legs three to four days after the beginning of the fever. Some people with dengue develop dengue hemorrhagic fever (DHF). Symptoms of DHF are characteristic of internal bleeding and include: severe abdominal pain, red patches on skin, bleeding from nose or gums, black stools, vomiting blood, drowsiness, cold and clammy skin and difficulty breathing.
    [Show full text]
  • Meeting on Prevention and Control of Crimean– Congo Haemorrhagic Fever in the Eastern Mediterranean Region
    Summary report on the WHO-EM/CSR/103/E Meeting on prevention and control of Crimean– Congo haemorrhagic fever in the Eastern Mediterranean Region Muscat, Oman 7–9 December 2015 WHO-EM/CSR/103/E Summary report on the Meeting on prevention and control of Crimean–Congo haemorrhagic fever in the Eastern Mediterranean Region Muscat, Oman 7–9 December 2015 © World Health Organization 2016 All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. Publications of the World Health Organization can be obtained from Knowledge Sharing and Production, World Health Organization, Regional Office for the Eastern Mediterranean, PO Box 7608, Nasr City, Cairo 11371, Egypt (tel: +202 2670 2535, fax: +202 2670 2492; email: [email protected]).
    [Show full text]
  • Transmission of Dengue Virus Without a Mosquito Vector: Nosocomial
    BRIEF REPORT Transmission of Dengue Virus had recently returned from Peru; the presumed mechanism of transmission was mucocutaneous exposure that occurred dur- without a Mosquito Vector: ing medical care. We describe both cases of dengue fever and Nosocomial Mucocutaneous review the ways that dengue virus can be transmitted without mosquito vectors. Transmission and Other Routes Case reports. Patient 1, a 48-year-old female traveler, pres- of Transmission ented in November 2002 with a 5-day history of fever, myalgia, Downloaded from https://academic.oup.com/cid/article/39/6/e56/359683 by guest on 30 September 2021 and headache. She had recently returned from Iquitos, Peru Lin H. Chen1,2,3 and Mary E. Wilson1,3 (on a trip that lasted from 1 through 10 November), where 1Harvard Medical School, and 2Travel Medicine Center and 3Division of she worked as a nurse on a medical mission and traveled Infectious Diseases, Mount Auburn Hospital, Cambridge, Massachusetts through the Amazon jungles. She stayed in a hotel that had unscreened, open windows. The patient had received hepatitis A virus, hepatitis B virus, and oral typhoid vaccines prior to We report a case of dengue fever in a Boston-area health travel, and she took mefloquine hydrochloride for malaria pro- care worker with no recent history of travel but with mu- phylaxis. She had received yellow fever vaccine in 1997. cocutaneous exposure to infected blood from a febrile trav- At examination, the patient’s temperature was 37.9ЊC. Ab- eler who had recently returned from Peru. Serologic tests normal findings included marked erythroderma, especially on confirmed acute dengue virus infection in both the traveler the patient’s back, and a maculopapular rash along her hairline.
    [Show full text]